The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease
The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease
复制标题
急性川崎病患者17型辅助T细胞/调节性T细胞失衡
DOI:
10.1111/j.1365-2249.2010.04236.x
复制
发表时间:
2010-10-01
影响因子:
4.6
通讯作者:
Zu, Y.
中科院分区:
文献类型:
--
作者:
Jia, S.;Li, C.;Zu, Y.
The study is designed to investigate the changes and roles of T helper type 17/regulatory T cells (Th17/Treg) in the immunological pathogenesis of Kawasaki disease (KD). In addition, we explore the alteration and significance of Th17 cells in patients with intravenous immune globulin‐resistant KD. Real‐time polymerase chain reaction (PCR) was used to evaluate the mRNA levels of interleukin (IL)‐17A/F, retinoic acid‐related orphan receptor (ROR)‐γt and forkhead box P3 (FoxP3) in CD4‐positive cells. The proportions of Th17 cells and CD4+CD25+FoxP3high Tregs were analysed by flow cytometry. Plasma cytokine [IL‐17A, IL‐6, IL‐23 and transforming growth factor (TGF)‐β] concentrations were measured by sandwich enzyme‐linked immunosorbent assay. Our data demonstrate that Th17 proportions and expression levels of cytokines (IL‐17, IL‐6 and IL‐23) and transcription factors (IL‐17A/F, ROR‐γt) were up‐regulated significantly, while Treg proportions and expression levels of Treg transcription factor (FoxP3) were down‐regulated significantly in children with acute KD (P < 0·01). Compared with the sensitive group, the Th17 proportions were up‐regulated significantly during the acute phase in immune globulin‐resistant KD (P < 0·01). The plasma IL‐17A, IL‐6 and IL‐23 concentrations in patients with KD were significantly higher compared with the concentrations in normal controls (NC) and infectious disease (ID). Plasma TGF‐β concentrations were markedly lower in the KD group than the NC and ID groups (P < 0·05). These results suggest that Th17/Treg cells imbalance exists in the patients with KD. Th17/T cells imbalance may be important factors causing disturbed immunological function and resulting in immunoglobulin‐resistant KD.